The DOI matches its Crossref record; 95 of the 95 references it cites were found in a registry or an index.
Enzyme-responsive nanomaterials for controlled drug delivery
Open accessAbstract
Enzymes underpin physiological function and exhibit dysregulation in many disease-associated microenvironments and aberrant cell processes. Exploiting altered enzyme activity and expression for diagnostics, drug targeting, and drug release is tremendously promising. When combined with booming research in nanobiotechnology, enzyme-responsive nanomaterials used for controlled drug release have achieved significant development and have been studied as an important class of drug delivery strategies in nanomedicine. In this review, we describe enzymes such as proteases, phospholipases and oxidoreductases that serve as delivery triggers. Subsequently, we explore recently developed enzyme-responsive nanomaterials with versatile applications for extracellular and intracellular drug delivery. We conclude by discussing future opportunities and challenges in this area.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Daniel, M.-C., & Astruc, D. (2004) · Chemical Reviews · doi:10.1021/cr030698+ · Cited by 12,446
Nanocarriers as an emerging platform for cancer therapy
Peer, D., Karp, J. M., Hong, S., Farokhzad, O. C., Margalit, R., & Langer, R. (2007) · Nature Nanotechnology · doi:10.1038/nnano.2007.387 · Cited by 8,710
Stimuli-responsive nanocarriers for drug delivery
Mura, S., Nicolas, J., & Couvreur, P. (2013) · Nature Materials · doi:10.1038/nmat3776 · Cited by 6,289
Recent advances with liposomes as pharmaceutical carriers
Torchilin, V. P. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1632 · Cited by 5,282
Cancer nanotechnology: opportunities and challenges
Ferrari, M. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1566 · Cited by 4,558
Nanoparticle therapeutics: an emerging treatment modality for cancer
Davis, M. E., Chen, Z., & Shin, D. M. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2614 · Cited by 4,233
Strategies in the design of nanoparticles for therapeutic applications
Petros, R. A., & DeSimone, J. M. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd2591 · Cited by 3,651
Biodegradable polymeric nanoparticles as drug delivery devices
Soppimath, K. S., Aminabhavi, T. M., Kulkarni, A. R., & Rudzinski, W. E. (2001) · Journal of Controlled Release · doi:10.1016/s0168-3659(00)00339-4 · Cited by 3,549
Long-Circulating and Target-Specific Nanoparticles: Theory to Practice
Moghimi, S. M., Hunter, A. C., & Murray, J. C. (2001) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01494-7 · Cited by 3,515
Impact of Nanotechnology on Drug Delivery
Farokhzad, O. C., & Langer, R. (2009) · ACS Nano · doi:10.1021/nn900002m · Cited by 3,348
Thermo- and pH-responsive polymers in drug delivery☆
SCHMALJOHANN, D. (2006) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2006.09.020 · Cited by 3,023
Bertrand, N., Wu, J., Xu, X., Kamaly, N., & Farokhzad, O. C. (2014) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2013.11.009 · Cited by 2,824
Gold nanoparticles in delivery applications☆
GHOSH, P., HAN, G., DE, M., KIM, C., & ROTELLO, V (2008) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2008.03.016 · Cited by 2,694
Nanoparticle and targeted systems for cancer therapy
Brannon-Peppas, L., & Blanchette, J. O. (2004) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2004.02.014 · Cited by 2,334
Tumor delivery of macromolecular drugs based on the EPR effect
Torchilin, V. (2011) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2010.03.011 · Cited by 2,032
Stimuli responsive polymers for biomedical applications
Alarcón, C. D. L. H., Pennadam, S., & Alexander, C. (2005) · Chem. Soc. Rev. · doi:10.1039/b406727d · Cited by 1,690
Magnetic nanomaterials for hyperthermia-based therapy and controlled drug delivery
Kumar, C. S. S. R., & Mohammad, F. (2011) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2011.03.008 · Cited by 1,666
Ligand-targeted therapeutics in anticancer therapy
Allen, T. M. (2002) · Nature Reviews Cancer · doi:10.1038/nrc903 · Cited by 1,647
In vivo imaging of tumors with protease-activated near-infrared fluorescent probes
Weissleder, R., Tung, C.-H., Mahmood, U., & Bogdanov, A. (1999) · Nature Biotechnology · doi:10.1038/7933 · Cited by 1,591
Regulation of matrix metalloproteinase expression in tumor invasion
Westermarck, J., & Kähäri, V. (1999) · The FASEB Journal · doi:10.1096/fasebj.13.8.781 · Cited by 1,494
Mohanraj, V. J., & Chen, Y. (2007) · Tropical Journal of Pharmaceutical Research · doi:10.4314/tjpr.v5i1.14634 · Cited by 1,217
pH-Sensitive nano-systems for drug delivery in cancer therapy
Liu, J., Huang, Y., Kumar, A., Tan, A., Jin, S., Mozhi, A., & Liang, X.-J. (2014) · Biotechnology Advances · doi:10.1016/j.biotechadv.2013.11.009 · Cited by 1,121
Multistage nanoparticle delivery system for deep penetration into tumor tissue
Wong, C., Stylianopoulos, T., Cui, J., Martin, J., Chauhan, V. P., Jiang, W., Popović, Z., Jain, R. K., Bawendi, M. G., & Fukumura, D. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1018382108 · Cited by 1,062
Self-Assembled Lipid−Polymer Hybrid Nanoparticles: A Robust Drug Delivery Platform
Zhang, L., Chan, J. M., Gu, F. X., Rhee, J.-W., Wang, A. Z., Radovic-Moreno, A. F., Alexis, F., Langer, R., & Farokhzad, O. C. (2008) · ACS Nano · doi:10.1021/nn800275r · Cited by 1,038
pH-Responsive Nanoparticles for Drug Delivery
Gao, W., Chan, J. M., & Farokhzad, O. C. (2010) · Molecular Pharmaceutics · doi:10.1021/mp100253e · Cited by 1,025
Liposomal Drug Delivery Systems: An Update Review
Samad, A., Sultana, Y., & Aqil, M. (2007) · Current Drug Delivery · doi:10.2174/156720107782151269 · Cited by 906
Temperature-responsive gels and thermogelling polymer matrices for protein and peptide delivery
Bromberg, L. (1998) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(97)00121-x · Cited by 838
Tumor imaging by means of proteolytic activation of cell-penetrating peptides
Jiang, T., Olson, E. S., Nguyen, Q. T., Roy, M., Jennings, P. A., & Tsien, R. Y. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0408191101 · Cited by 822
Nanomedicine: Developing smarter therapeutic and diagnostic modalities☆
FAROKHZAD, O., & LANGER, R. (2006) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2006.09.011 · Cited by 800
Enzyme-responsive nanoparticles for drug release and diagnostics
de la Rica, R., Aili, D., & Stevens, M. M. (2012) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.01.002 · Cited by 765
Enzyme-responsive polymeric assemblies, nanoparticles and hydrogels
Hu, J., Zhang, G., & Liu, S. (2012) · Chemical Society Reviews · doi:10.1039/c2cs35103j · Cited by 722
Stimuli-responsive polymers and their applications in drug delivery
Bawa, P., Pillay, V., Choonara, Y. E., & du Toit, L. C. (2009) · Biomedical Materials · doi:10.1088/1748-6041/4/2/022001 · Cited by 641
Wang, H., Zhao, Y., Wu, Y., Hu, Y.-L., Nan, K., Nie, G., & Chen, H. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.07.032 · Cited by 603
Electro-responsive drug delivery from hydrogels
Murdan, S. (2003) · Journal of Controlled Release · doi:10.1016/s0168-3659(03)00303-1 · Cited by 585
Olson, E. S., Jiang, T., Aguilera, T. A., Nguyen, Q. T., Ellies, L. G., Scadeng, M., & Tsien, R. Y. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0910283107 · Cited by 567
Tailoring nanocarriers for intracellular protein delivery
Gu, Z., Biswas, A., Zhao, M., & Tang, Y. (2011) · Chemical Society Reviews · doi:10.1039/c0cs00227e · Cited by 543
Self-citationCancer Nanomedicine: From Drug Delivery to Imaging
Chow, E. K.-H., & Ho, D. (2013) · Science Translational Medicine · doi:10.1126/scitranslmed.3005872 · Cited by 491
Enzyme-responsive materials: a new class of smart biomaterials
Ulijn, R. V. (2006) · Journal of Materials Chemistry · doi:10.1039/b601776m · Cited by 467
Injectable Nano-Network for Glucose-Mediated Insulin Delivery
Gu, Z., Aimetti, A. A., Wang, Q., Dang, T. T., Zhang, Y., Veiseh, O., Cheng, H., Langer, R. S., & Anderson, D. G. (2013) · ACS Nano · doi:10.1021/nn400630x · Cited by 462
Self-citationLuo, Z., Cai, K., Hu, Y., Zhao, L., Liu, P., Duan, L., & Yang, W. (2011) · Angewandte Chemie International Edition · doi:10.1002/anie.201005061 · Cited by 440
Glucose-Responsive Microgels Integrated with Enzyme Nanocapsules for Closed-Loop Insulin Delivery
Gu, Z., Dang, T. T., Ma, M., Tang, B. C., Cheng, H., Jiang, S., Dong, Y., Zhang, Y., & Anderson, D. G. (2013) · ACS Nano · doi:10.1021/nn401617u · Cited by 428
Self-citationStimuli-responsive nanomaterials for therapeutic protein delivery
Lu, Y., Sun, W., & Gu, Z. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.08.015 · Cited by 415
Self-citationPark, C., Kim, H., Kim, S., & Kim, C. (2009) · Journal of the American Chemical Society · doi:10.1021/ja9061085 · Cited by 396
Emerging micro- and nanotechnology based synthetic approaches for insulin delivery
Mo, R., Jiang, T., Di, J., Tai, W., & Gu, Z. (2014) · Chemical Society Reviews · doi:10.1039/c3cs60436e · Cited by 386
Self-citationChen, C., Geng, J., Pu, F., Yang, X., Ren, J., & Qu, X. (2011) · Angewandte Chemie International Edition · doi:10.1002/anie.201005471 · Cited by 335
Roles of Matrix Metalloproteinases in Tumor Metastasis and Angiogenesis
Yoon, S.-O., Park, S.-J., Yun, C.-H., & Chung, A.-S. (2003) · BMB Reports · doi:10.5483/bmbrep.2003.36.1.128 · Cited by 320
Bernardos, A., Mondragón, L., Aznar, E., Marcos, M. D., Martínez-Máñez, R., Sancenón, F., Soto, J., Barat, J. M., Pérez-Payá, E., Guillem, C., et al. (2010) · ACS Nano · doi:10.1021/nn101499d · Cited by 310
Current directions in core–shell nanoparticle design
Schärtl, W. (2010) · Nanoscale · doi:10.1039/c0nr00028k · Cited by 309
Emerging nanotechnology-based strategies for the identification of microbial pathogenesis
Kaittanis, C., Santra, S., & Perez, J. M. (2010) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2009.11.013 · Cited by 308
Jiang, T., Mo, R., Bellotti, A., Zhou, J., & Gu, Z. (2014) · Advanced Functional Materials · doi:10.1002/adfm.201303222 · Cited by 298
Self-citationButterfield, D. A., Hardas, S. S., & Lange, M. L. B. (2010) · Journal of Alzheimer's Disease · doi:10.3233/jad-2010-1375 · Cited by 262
Liposome circulation time and tumor targeting: implications for cancer chemotherapy
Gabizon, A. A. (1995) · Advanced Drug Delivery Reviews · doi:10.1016/0169-409x(95)00030-b · Cited by 255
Peptides in cancer nanomedicine: Drug carriers, targeting ligands and protease substrates
Zhang, X.-X., Eden, H. S., & Chen, X. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.10.023 · Cited by 243
Vadas, P., Browning, J. L., Edelson, J. D., et al. (1993) · PubMed · Cited by 239
Enzyme Sensitive Synthetic Polymer Micelles Based on the Azobenzene Motif
Rao, J., & Khan, A. (2013) · Journal of the American Chemical Society · doi:10.1021/ja407514z · Cited by 207
Hu, C.-M. J., Fang, R. H., Luk, B. T., & Zhang, L. (2014) · Nanoscale · doi:10.1039/c3nr05444f · Cited by 201
Enzyme-triggered nanomedicine: Drug release strategies in cancer therapy (Invited Review)
Andresen, T. L., Thompson, D. H., & Kaasgaard, T. (2010) · Molecular Membrane Biology · doi:10.3109/09687688.2010.515950 · Cited by 200
Cyclodextrin-covered gold nanoparticles for targeted delivery of an anti-cancer drug
Park, C., Youn, H., Kim, H., Noh, T., Kook, Y. H., Oh, E. T., Park, H. J., & Kim, C. (2009) · Journal of Materials Chemistry · doi:10.1039/b816209c · Cited by 200
Tumor and stromal expression of matrix metalloproteinases and their role in tumor progression.
Crawford, H. C., & Matrisian, L. M. (1995) · PubMed · Cited by 199
Terada, T., Iwai, M., Kawakami, S., Yamashita, F., & Hashida, M. (2006) · Journal of Controlled Release · doi:10.1016/j.jconrel.2005.12.023 · Cited by 197
Hu, Q., Gu, G., Liu, Z., Jiang, M., Kang, T., Miao, D., Tu, Y., Pang, Z., Song, Q., Yao, L., et al. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2012.10.048 · Cited by 194
Self-citationBacterial phospholipases and pathogenesis
Schmiel, D. H., & Miller, V. L. (1999) · Microbes and Infection · doi:10.1016/s1286-4579(99)00205-1 · Cited by 193
Harnoy, A. J., Rosenbaum, I., Tirosh, E., Ebenstein, Y., Shaharabani, R., Beck, R., & Amir, R. J. (2014) · Journal of the American Chemical Society · doi:10.1021/ja413036q · Cited by 191
Enzyme‐Responsive Nanoparticle Systems
Ghadiali, J. E., & Stevens, M. M. (2008) · Advanced Materials · doi:10.1002/adma.200703158 · Cited by 188
Gu, G., Xia, H., Hu, Q., Liu, Z., Jiang, M., Kang, T., Miao, D., Tu, Y., Pang, Z., Song, Q., et al. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2012.09.044 · Cited by 184
Self-citationCyclodextrin-Modified Gold Nanospheres
Liu, J., Ong, W., Román, E., Lynn, M. J., & Kaifer, A. E. (2000) · Langmuir · doi:10.1021/la991519f · Cited by 183
Emerging roles for phospholipase A2 enzymes in cancer
Scott, K. F., Sajinovic, M., Hein, J., Nixdorf, S., Galettis, P., Liauw, W., de Souza, P., Dong, Q., Graham, G. G., & Russell, P. J. (2010) · Biochimie · doi:10.1016/j.biochi.2010.03.019 · Cited by 176
Kundu, J. K., & Surh, Y.-J. (2010) · Pharmaceutical Research · doi:10.1007/s11095-010-0096-8 · Cited by 173
Popat, A., Ross, B. P., Liu, J., Jambhrunkar, S., Kleitz, F., & Qiao, S. Z. (2012) · Angewandte Chemie International Edition · doi:10.1002/anie.201206416 · Cited by 164
Phospholipase A2 as targets for anti-cancer drugs
Cummings, B. S. (2007) · Biochemical Pharmacology · doi:10.1016/j.bcp.2007.04.021 · Cited by 163
Andresen, T. L., Davidsen, J., Begtrup, M., Mouritsen, O. G., & Jørgensen, K. (2004) · Journal of Medicinal Chemistry · doi:10.1021/jm031029r · Cited by 158
Liu, D., Bimbo, L. M., Mäkilä, E. M., Villanova, F., Kaasalainen, M. H., Herranz‐Blanco, B., Caramella, C. M., Lehto, V., Salonen, J., Herzig, K., et al. (2013) · Journal of Controlled Release · doi:10.1016/j.jconrel.2013.05.036 · Cited by 158
Protein Nanocapsule Weaved with Enzymatically Degradable Polymeric Network
Gu, Z., Yan, M., Hu, B., Joo, K., Biswas, A., Huang, Y., Lu, Y., Wang, P., & Tang, Y. (2009) · Nano Letters · doi:10.1021/nl902935b · Cited by 144
Self-citationExpression of group IIa secretory phospholipase A2 increases with prostate tumor grade.
Graff, J. R., Konicek, B. W., Deddens, J. A., Chedid, M., Hurst, B. M., Colligan, B. M., Neubauer, B. L., Carter, H. W., & Carter, J. H. (2001) · PubMed · Cited by 136
Markland, P., Zhang, Y., Amidon, G. L., & Yang, V. C.-M. (1999) · Journal of Biomedical Materials Research · Cited by 134
Phospholipase A2 expression in tumours: a target for therapeutic intervention?
Laye, J. P., & Gill, J. H. (2003) · Drug Discovery Today · doi:10.1016/s1359-6446(03)02754-5 · Cited by 127
Phospholipase C-γ1 in tumor progression
Wells, A. H., & Grandis, J. R. (2003) · Clinical & Experimental Metastasis · doi:10.1023/a:1024088922957 · Cited by 127
Chien, M., Carlini, A. S., Hu, D., Barback, C. V., Rush, A. M., Hall, D. J., Orr, G., & Gianneschi, N. C. (2013) · Journal of the American Chemical Society · doi:10.1021/ja408182p · Cited by 113
A pH/Enzyme-responsive tumor-specific delivery system for doxorubicin
Dong, L., Xia, S., Wu, K., Huang, Z. D., Chen, H., Chen, J., & Zhang, J. (2010) · Biomaterials · doi:10.1016/j.biomaterials.2010.04.049 · Cited by 108
Endoprotease-Mediated Intracellular Protein Delivery Using Nanocapsules
Biswas, A., Joo, K., Liu, J., Zhao, M., Fan, G., Wang, P., Gu, Z., & Tang, Y. (2011) · ACS Nano · doi:10.1021/nn1031005 · Cited by 104
Self-citationPeptide-Based Biomaterials for Protease-Enhanced Drug Delivery
Law, B., Weissleder, R., & Tung, C. (2006) · Biomacromolecules · doi:10.1021/bm050920f · Cited by 97
Wan, Y., Han, J., Fan, G., Zhang, Z., Gong, T., & Sun, X. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2012.12.051 · Cited by 89
Mondragón, L., Mas, N., Ferragud, V., de la Torre, C., Agostini, A., Martínez‐Máñez, R., Sancenón, F., Amorós, P., Pérez‐Payá, E., & Orzáez, M. (2014) · Chemistry - A European Journal · doi:10.1002/chem.201400148 · Cited by 88
Kang, J., Asai, D., Kim, J.-H., Mori, T., Toita, R., Tomiyama, T., Asami, Y., Oishi, J., Sato, Y., Niidome, T., et al. (2008) · Journal of the American Chemical Society · doi:10.1021/ja805364s · Cited by 83
Enzyme-directed assembly and manipulation of organic nanomaterials
Hahn, M. E., & Gianneschi, N. C. (2011) · Chemical Communications · doi:10.1039/c1cc15220c · Cited by 82
Linderoth, L., Peters, G. H. J., Madsen, R., & Andresen, T. L. (2009) · Angewandte Chemie International Edition · doi:10.1002/anie.200805241 · Cited by 79
Folding graft copolymer with pendant drug segments for co-delivery of anticancer drugs
Tai, W., Mo, R., Lü, Y., Jiang, T., & Gu, Z. (2014) · Biomaterials · doi:10.1016/j.biomaterials.2014.05.004 · Cited by 78
Self-citationTargeted Enzyme‐Responsive Drug Carriers: Studies on the Delivery of a Combination of Drugs
Lee, M., Baek, K., Jin, H. J., Jung, Y., & Shin, I. (2004) · Angewandte Chemie International Edition · doi:10.1002/anie.200353204 · Cited by 76
Lopes, J., Santos, G., Barata, P., Oliveira, R., & Lopes, C. M. (2013) · Current Pharmaceutical Design · doi:10.2174/13816128113199990698 · Cited by 75
Wang, S., Deng, Y., Xu, H., Wu, H., QIU, Y., & CHEN, D. (2005) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2005.07.004 · Cited by 74
An enzyme-sensitive probe for photoacoustic imaging and fluorescence detection of protease activity
Xia, X., Yang, M., Oetjen, L. K., Zhang, Y. S., Li, Q., Chen, J., & Younan Xia, A. (2011) · Nanoscale · doi:10.1039/c0nr00874e · Cited by 72
Triggerable liposomal fusion by enzyme cleavage of a novel peptide–lipid conjugate
Pak, C. C., Ali, S., Janoff, A. S., et al. (1998) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/s0005-2736(98)00041-8 · Cited by 66
Intelligent Design of Multifunctional lipid-coated Nanoparticle Platforms for Cancer Therapy
Ramishetti, S., & Huang, L. (2012) · Therapeutic Delivery · doi:10.4155/tde.12.127 · Cited by 42
Probing protease activity by single-fluorescent-protein nanocapsules
Gu, Z., Biswas, A., Joo, K., Hu, B., Wang, P., & Tang, Y. (2010) · Chemical Communications · doi:10.1039/c0cc01439g · Cited by 39
Self-citationEnzyme-assisted photolithography for spatial functionalization of hydrogels
Gu, Z., & Tang, Y. (2010) · Lab on a Chip · doi:10.1039/c001335h · Cited by 30
Self-citation
Cited by
Analysis of nanoparticle delivery to tumours
Wilhelm, S., Tavares, A. J., Dai, Q., Ohta, S., Audet, J., Dvorak, H. F., & Chan, W. C. W. (2016) · Nature Reviews Materials · doi:10.1038/natrevmats.2016.14 · Cited by 5,218
Kamaly, N., Yameen, B., Wu, J., & Farokhzad, O. C. (2016) · Chemical Reviews · doi:10.1021/acs.chemrev.5b00346 · Cited by 3,070
Yang, G., Xu, L., Chao, Y., Xu, J., Sun, X., Wu, Y., Peng, R., & Liu, Z. (2017) · Nature Communications · doi:10.1038/s41467-017-01050-0 · Cited by 1,477
Stimuli-responsive nanocarriers for drug delivery, tumor imaging, therapy and theranostics
Mi, P. (2020) · Theranostics · doi:10.7150/thno.38069 · Cited by 830
Recent advances of cocktail chemotherapy by combination drug delivery systems
Hu, Q., Sun, W., Wang, C., & Gu, Z. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2015.10.022 · Cited by 625
Self-citation
Metadata
- Authors
- Hu, Q., Katti, P. S., & Gu, Z.
- Venue
- Nanoscale
- Publisher
- Royal Society of Chemistry (RSC)
- Published
- 2014-09-24
- Volume
- 6
- Issue
- 21
- Pages
- 12273-12286
- ISSN
- 2040-3364 (ISSN-L)
- 2040-3372
- OpenAlex
- W2146536848
- Cited by
- 668
- References
- 95
- FWCI
- 10.61
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.